Update in the US Supreme Court landmark Myriad gene patent case

A decision is expected later this month from the US Supreme Court in the case of Association for Molecular Pathology v Myriad Genetics Inc, which is considering the patentability of isolated human genes claimed in patents held by Myriad Genetics Inc. Commentators present at the oral arguments, which were heard in April 2013, have indicated

Push for gene patent ban in Australia resurrected

Seemingly unsatisfied by two recent Senate Inquiry Reports which rejected proposals to legislate against gene patents, the proponents of gene patent reform appear to have resurrected their cause via a new Private Members’ Bill which once again seeks to ban gene patents in Australia. In September 2011, we reported that an attempt to ban gene